Royce & Associates LP Biote Corp. Transaction History
Royce & Associates LP
- $10.3 Billion
- Q2 2024
A detailed history of Royce & Associates LP transactions in Biote Corp. stock. As of the latest transaction made, Royce & Associates LP holds 14,290 shares of BTMD stock, worth $74,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,290
Previous 14,290
-0.0%
Holding current value
$74,450
Previous $82,000
29.27%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
76Shares Held
15.9MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$19.6 Million12.3% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$12.7 Million6.61% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$8.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$7.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.29MShares$6.69 Million0.05% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $39.5M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...